WebbAntibody Surface Profiling Identifies Glycoforms in Multiple Myeloma as Targets for Immunotherapy: From Antibody Derivatives to Mimetic Peptides for Killing Tumor Cells … WebbSialofucosylation Enables Platelet Binding to Myeloma Cells via P-Selectin and Suppresses NK Cell-Mediated Cytotoxicity by Alessandro Natoni 13 Apr 2024 10:57:07
Natural Killer Cells in the Malignant Niche of Multiple …
Webb5 apr. 2024 · It is shown that the presence of SLea/x induced a strong binding of MM cells to P- selectin, leading to specific and direct interactions with platelets, which could be … WebbMultiple myeloma (MM) is a haematologic malignancy with significant improvements in the overall survival over the last decade. However, patients still relapse and die due to a … raid shadow legends schmiede
Potential of NK cells in multiple Myeloma therapy - PubMed
Webb11 jan. 2024 · NK cells represent 2–31% of peripheral blood (PB) lymphocytes ( 30 ). Although the organ and tissue distribution and circulation of NK cells are not fully understood, they are also present in the bone marrow (BM), liver, spleen, lungs, uterus, … Webb25 juni 2015 · Phase 1 Clinical Trial to Evaluate Security and Dose of Expanded and Activated Autologous NK Cells Infusions in Consolidation of Multiple Myeloma … WebbChallenges in αCD38-chimeric antigen receptor (CAR)-expressing natural killer (NK) cell-based immunotherapy in multiple myeloma: Harnessing the CD38dim phenotype of … raid shadow legends scarab king champion